Evidence map›Paper›PMID 24643163›Full record

ArticleTranslational psychiatry2014

Epistatic interaction of genetic depression risk variants in the human subgenual cingulate cortex during memory encoding.

B H Schott, A Assmann, P Schmierer, J Soch, S Erk, M Garbusow, S Mohnke, L Pöhland, N Romanczuk-Seiferth, A Barman and 18 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Translational psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Genetic Approaches to Understanding Psychiatric Disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2017
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 5 institutions in 1 country.

B H Schott1] Department of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany [2] Leibniz Institute for Neurobiology, Magdeburg, Germany [3] Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany [4] Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany.
A Assmann1] Leibniz Institute for Neurobiology, Magdeburg, Germany [2] Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.
P Schmierer1] Department of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany [2] Berlin School of Mind and Brain, Humboldt University Berlin, Berlin, Germany.
J Soch1] Department of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany [2] Leibniz Institute for Neurobiology, Magdeburg, Germany [3] Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.
S ErkDepartment of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany.
M GarbusowDepartment of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany.
S MohnkeDepartment of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany.
L PöhlandDepartment of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany.
N Romanczuk-SeiferthDepartment of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany.
A BarmanLeibniz Institute for Neurobiology, Magdeburg, Germany.
T WüstenbergDepartment of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany.
L HaddadCentral Institute of Mental Health, Mannheim, Germany.
O GrimmCentral Institute of Mental Health, Mannheim, Germany.
S WittCentral Institute of Mental Health, Mannheim, Germany.
S Richter1] Leibniz Institute for Neurobiology, Magdeburg, Germany [2] University of Salzburg, Salzburg, Austria.
M KleinLeibniz Institute for Neurobiology, Magdeburg, Germany.
H SchützeMedical Faculty, Otto-von-Guericke University, Magdeburg, Germany.
T W Mühleisen1] University of Bonn, Bonn, Germany [2] Research Center Jülich, Jülich, Germany.
S Cichon1] University of Bonn, Bonn, Germany [2] Research Center Jülich, Jülich, Germany [3] University of Basel, Basel, Switzerland.
M RietschelCentral Institute of Mental Health, Mannheim, Germany.
M M NoethenUniversity of Bonn, Bonn, Germany.
H TostCentral Institute of Mental Health, Mannheim, Germany.
E D Gundelfinger1] Leibniz Institute for Neurobiology, Magdeburg, Germany [2] Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany [3] Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany.
E Düzel1] Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany [2] Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany [3] Helmholtz Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
A HeinzDepartment of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany.
A Meyer-LindenbergCentral Institute of Mental Health, Mannheim, Germany.
C I Seidenbecher1] Leibniz Institute for Neurobiology, Magdeburg, Germany [2] Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany.
H WalterDepartment of Psychiatry, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DECentral Institute of Mental Health · DELeibniz Institute for Neurobiology · DEOtto-von-Guericke University Magdeburg · DEUniversity of Bonn · DE

Funding

Medical Research Council G1002276
6 · The paper itself

Abstract

Recent genome-wide association studies have pointed to single-nucleotide polymorphisms (SNPs) in genes encoding the neuronal calcium channel CaV1.2 (CACNA1C; rs1006737) and the presynaptic active zone protein Piccolo (PCLO; rs2522833) as risk factors for affective disorders, particularly major depression. Previous neuroimaging studies of depression-related endophenotypes have highlighted the role of the subgenual cingulate cortex (CG25) in negative mood and depressive psychopathology. Here, we aimed to assess how recently associated PCLO and CACNA1C depression risk alleles jointly affect memory-related CG25 activity as an intermediate phenotype in clinically healthy humans. To investigate the combined effects of rs1006737 and rs2522833 on the CG25 response, we conducted three functional magnetic resonance imaging studies of episodic memory formation in three independent cohorts (N=79, 300, 113). An epistatic interaction of PCLO and CACNA1C risk alleles in CG25 during memory encoding was observed in all groups, with carriers of no risk allele and of both risk alleles showing higher CG25 activation during encoding when compared with carriers of only one risk allele. Moreover, PCLO risk allele carriers showed lower memory performance and reduced encoding-related hippocampal activation. In summary, our results point to region-specific epistatic effects of PCLO and CACNA1C risk variants in CG25, potentially related to episodic memory. Our data further suggest that genetic risk factors on the SNP level do not necessarily have additive effects but may show complex interactions. Such epistatic interactions might contribute to the 'missing heritability' of complex phenotypes.

Indexed as

Memory, EpisodicAdultCalcium Channels, L-TypeCytoskeletal ProteinsEpistasis, GeneticFunctional NeuroimagingGyrus CinguliHippocampusHumansMagnetic Resonance ImagingMajor Depressive DisorderNeuropeptidesPhenotypePolymorphism, Single NucleotideCACNA1C protein, humanCalcium Channels, L-TypeCytoskeletal ProteinsNeuropeptidesPCLO protein, human

Identifiers

PMID24643163
PMCPMC3966038
OpenAlexW2113817227

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.